Lutz Herrmann

Title: Lutz Herrmann: Innovator in Ciliate Cell Research

Introduction

Lutz Herrmann is a notable inventor based in Herne, Germany. He has made significant contributions to the field of biotechnology, particularly in the study of ciliate cells. With a total of 2 patents, Herrmann's work focuses on innovative methods that enhance our understanding of cellular processes.

Latest Patents

Herrmann's latest patents include groundbreaking research on nucleic acids and their applications. One of his patents addresses the deficiency of bifunctional dihydrofolate reductase-thymidylate synthase in ciliate cells. This method claims to produce a ciliate cell with reduced or essentially no dihydrofolate reductase (DHFS) activity or reduced or essentially no thymidylate synthase (TS) activity, or both. Another patent involves a method for characterizing samples by monitoring fluctuating intensities of radiation emitted, scattered, and/or reflected by the units in a measurement volume. This method includes steps for measuring photon counts and determining specific brightness functions.

Career Highlights

Lutz Herrmann is currently associated with Cilian AG, where he continues to advance his research in ciliate cell technology. His innovative approaches have positioned him as a key figure in his field, contributing to the development of new methodologies that have practical applications in biotechnology.

Collaborations

Throughout his career, Herrmann has collaborated with notable colleagues, including Thomas Weide and Marcus Hartmann. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation.

Conclusion

Lutz Herrmann's contributions to biotechnology, particularly in the realm of ciliate cells, underscore his role as a leading inventor. His patents reflect a commitment to advancing scientific knowledge and developing practical applications that benefit the field.